Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.207
0.00 (0.15%)
At close: Dec 20, 2024, 4:00 PM
0.201
-0.006 (-2.95%)
After-hours: Dec 20, 2024, 6:52 PM EST
Vincerx Pharma Stock Forecast
VINC's stock price has decreased by -68.14% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Vincerx Pharma stock has a target of 2.00, which predicts an increase of 865.72% from the current stock price of 0.21.
Analyst Consensus: Buy
* Price targets were last updated on Oct 8, 2024.
Analyst Ratings
The average analyst rating for Vincerx Pharma stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Maintains $4 → $2 | Buy | Maintains | $4 → $2 | +865.72% | Oct 8, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $5 | Buy | Reiterates | $5 | +2,314.29% | Sep 7, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +1,348.58% | Nov 17, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.78
from -1.89
EPS Next Year
-0.47
from -0.78
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | 231,000 |
Avg | n/a | n/a | 224,400 |
Low | n/a | n/a | 215,600 |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.78 | -0.34 | -0.60 |
Avg | -0.78 | -0.47 | -0.58 |
Low | -0.76 | -0.59 | -0.56 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.